Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial

被引：1
|
作者：
Pedicino, Daniela [1 ]
Volpe, Massimo [2 ,3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, Via Grottarossa 1035, Rome, Italy
[3] IRCCS San Raffaele Roma, Via Valcannuta 250, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 38期
关键词：
GLP-1 RECEPTOR AGONISTS; MORTALITY;
D O I：
10.1093/eurheartj/ehae429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3910 / 3911
页数：2
相关论文
共 50 条
  • [1] Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
    Mahaffey, Kenneth W.
    Tuttle, Katherine R.
    Arici, Mustafa
    Baeres, Florian M. M.
    Bakris, George
    Charytan, David M.
    Cherney, David Z., I
    Chernin, Gil
    Correa-Rotter, Ricardo
    Gumprecht, Janusz
    Idorn, Thomas
    Pugliese, Giuseppe
    Rasmussen, Ida Kirstine Bull
    Rasmussen, Soren
    Rossing, Peter
    Sokareva, Ekaterina
    Mann, Johannes F. E.
    Perkovic, Vlado
    Pratley, Richard
    EUROPEAN HEART JOURNAL, 2024, : 1096 - 1108
  • [2] Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Disease in the FLOW Trial
    Pratley, Richard E.
    Tuttle, Katherine R.
    Rossing, Peter
    Rasmussen, Soren
    Perkovic, Vlado
    Nielsen, Olav Wendelboe
    Mann, Johannes F. E.
    MacIsaac, Richard J.
    Kosiborod, Mikhail N.
    Kamenov, Zdravko
    Idorn, Thomas
    Hansen, Marco Bo
    Hadjadj, Samy
    Bakris, George
    Baeres, Florian M. M.
    Mahaffey, Kenneth W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (17) : 1615 - 1628
  • [3] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [4] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [5] A meta-analytic review of the safety and efficacy of semaglutide in type 2 diabetes mellitus and chronic kidney disease patients
    Ashraf, Taimoor
    Bai, Shevita
    Kumar, Aashish
    Sagar, Raja Subhash
    Saloni, Fnu
    Kumar, Anesh
    Kumar, Rohet
    Pahwani, Ashvin
    Kumar, Vikash
    Hassaan, Muhammad
    Khatri, Govinda
    Jabbar, Maheen
    Deepak, Fnu
    Yusuf, Salih Abdella
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (04): : 2278 - 2285
  • [6] Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial
    McGuire, Darren K.
    Busui, Rodica P.
    Deanfield, John
    Inzucchi, Silvio E.
    Mann, Johannes F. E.
    Marx, Nikolaus
    Mulvagh, Sharon L.
    Poulter, Neil
    Engelmann, Mads D. M.
    Hovingh, G. Kees
    Ripa, Maria Sejersten
    Gislum, Mette
    Brown-Frandsen, Kirstine
    Buse, John B.
    DIABETES OBESITY & METABOLISM, 2023, 25 (07) : 1932 - 1941
  • [7] A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
    Pfeffer, Marc A.
    Burdmann, Emmanuel A.
    Chen, Chao-Yin
    Cooper, Mark E.
    de Zeeuw, Dick
    Eckardt, Kai-Uwe
    Feyzi, Jan M.
    Ivanovich, Peter
    Kewalramani, Reshma
    Levey, Andrew S.
    Lewis, Eldrin F.
    McGill, Janet B.
    McMurray, John J. V.
    Parfrey, Patrick
    Parving, Hans-Henrik
    Remuzzi, Giuseppe
    Singh, Ajay K.
    Solomon, Scott D.
    Toto, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) : 2019 - 2032
  • [8] Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
    Ebert, Thomas
    Anker, Stefan D.
    Ruilope, Luis M.
    Fioretto, Paola
    Fonseca, Vivian
    Umpierrez, Guillermo E.
    Birkenfeld, Andreas L.
    Lawatscheck, Robert
    Scott, Charlie
    Rohwedder, Katja
    Rossing, Peter
    DIABETES CARE, 2024, 47 (03) : 362 - 370
  • [9] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [10] Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study
    Chu, Lisa
    Fuller, Mark
    Jervis, Kathyrn
    Ciaccia, Antonio
    Abitbol, Alexander
    CLINICAL THERAPEUTICS, 2021, 43 (09) : 1558 - +
12345